Search
Generic filters

ASXC – Asensus Surgical Inc

Not Compliant

The company’s impure earnings are more than 5% of its total revenues.

Asensus Surgical, Inc. is a medical device company. The Company is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The Company is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.

AAOIFI ✗

Debt ÷ Market cap (MC)0
Non-Compliant Assets ÷ MC18.01
Impure Income (incl. Interest)27.16
Impure Income%
Interest Income27.16%
Total27.16%